NCT04564274View on ClinicalTrials.gov

COV2Base-A Rare Disease by COVID Study

CompletedOBSERVATIONAL
Enrollment

1,748

Participants

Timeline

Start Date

October 4, 2020

Primary Completion Date

May 20, 2022

Study Completion Date

May 20, 2022

Conditions
Chronic Health ConditionsOlder Age is Associated With Increased Pathogenicity
Trial Locations (1)

20892

National Heart, Lung and Blood Institute (NHLBI), Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT04564274 - COV2Base-A Rare Disease by COVID Study | Biotech Hunter | Biotech Hunter